Charles DeBattista
Publication Details
-
Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression.
Biol Psychiatry. 2006; (12): 1343-9
Abnormalities in the hypothalamic pituitary adrenal axis have been implicated in the pathophysiology of psychotic major depression (PMD). Recent studies have suggested that the antiglucocorticoid, mifepristone might have a role in the treatment of PMD. The current study tested the efficacy of mifepristone treatment of the psychotic symptoms of PMD.

